Publicacions destacades

Projectes destacats

  • Patient-derived liver biopsy-organoids for personalized medicine in NAFLD (Non-Alcoholic Fatty Liver Disease): towards real time assessment of drug response (B-ORG)

    Investigador/a principal: Pau Sancho Bru
    Finançador: Ministerio de Ciencia e Innovación
    Codi: IBEC_ProyectCompl22
    Durada: 13/04/2023 - 31/12/2024
  • Dissecting the role of the 14q32 region in hepatoblastoma Hblast14

    Investigador/a principal: Pau Sancho Bru
    Finançador: Worldwide Cancer Research
    Codi: INT_WWCR_22
    Durada: 01/04/2023 - 31/03/2026
  • Off the shelf hepatic stellate cells for liver disease modeling and drug screening

    Investigador/a principal: Pau Sancho Bru
    Finançador: Instituto de Salud Carlos III
    Codi: FIS_DTS22
    Durada: 01/01/2023 - 31/12/2025
  • Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH transition to inform early prevention and treatment strategies. (Halt-RONIN)

    Investigador/a principal: Pau Sancho Bru
    Finançador: European Commission
    Durada: 01/12/2022 - 30/11/2026
  • Mechanisms of impaired liver regeneration in alcoholic liver disease: drivers and therapeutic targets

    Investigador/a principal: Pau Sancho Bru
    Finançador: Instituto de Salud Carlos III
    Codi: PI20/00765
    Durada: 01/01/2021 - 31/12/2023